a public good project by the
Synthesis
Company
of California

© 2026

Valeria Tomati | doi.page

0 works0 citations0 h-index

Valeria Tomati

Istituto Giannina Gaslini(IT)Istituti di Ricovero e Cura a Carattere Scientifico(IT)

Publications by Year

Research Areas

Cystic Fibrosis Research Advances, Neonatal Respiratory Health Research, Advanced biosensing and bioanalysis techniques, Inhalation and Respiratory Drug Delivery, Tracheal and airway disorders

Most-Cited Works

→ Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia(2012)161 cited
→ Influence of cell background on pharmacological rescue of mutant CFTR(2010)131 cited
→ Goblet Cell Hyperplasia Requires High Bicarbonate Transport To Support Mucin Release(2016)90 cited
→ Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling(2011)88 cited
→ Pharmacological Inhibition of the Ubiquitin Ligase RNF5 Rescues F508del-CFTR in Cystic Fibrosis Airway Epithelia(2018)72 cited
→ Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment(2021)69 cited

→ Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations(2011)

61 cited

→ Genetic Inhibition Of The Ubiquitin Ligase Rnf5 Attenuates Phenotypes Associated To F508del Cystic Fibrosis Mutation(2015)55 cited

→ The L467F-F508del Complex Allele Hampers Pharmacological Rescue of Mutant CFTR by Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Patients: The Value of the Ex Vivo Nasal Epithelial Model to Address Non-Responders to CFTR-Modulating Drugs(2022)48 cited

→ Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel(2020)47 cited